Stéphane Giraudier

6.3k total citations
117 papers, 3.8k citations indexed

About

Stéphane Giraudier is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Stéphane Giraudier has authored 117 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Genetics, 83 papers in Hematology and 45 papers in Rheumatology. Recurrent topics in Stéphane Giraudier's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (71 papers), Chronic Myeloid Leukemia Treatments (40 papers) and Eosinophilic Disorders and Syndromes (36 papers). Stéphane Giraudier is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (71 papers), Chronic Myeloid Leukemia Treatments (40 papers) and Eosinophilic Disorders and Syndromes (36 papers). Stéphane Giraudier collaborates with scholars based in France, Switzerland and United States. Stéphane Giraudier's co-authors include William Vainchenker, Bruno Cassinat, Jean‐Jacques Kiladjian, M Tulliez, Fabrice Wendling, Jean‐Luc Villeval, Carole Tonetti, Hédia Chagraoui, Michel Tulliez and Stefan N. Constantinescu and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Stéphane Giraudier

112 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphane Giraudier France 32 2.4k 2.3k 1.4k 1.2k 381 117 3.8k
Susan O’Brien United States 29 1.3k 0.5× 2.2k 1.0× 949 0.7× 441 0.4× 575 1.5× 69 3.1k
Luca Malcovati Italy 47 3.8k 1.6× 5.9k 2.5× 2.1k 1.5× 396 0.3× 574 1.5× 187 7.5k
Chloé James France 22 3.1k 1.3× 2.4k 1.0× 2.1k 1.5× 1.3k 1.0× 622 1.6× 73 4.3k
Jaroslav F. Prchal Canada 19 1.5k 0.6× 1.5k 0.6× 676 0.5× 499 0.4× 222 0.6× 39 2.4k
Jan Samuelsson Sweden 26 1.9k 0.8× 1.9k 0.8× 1.2k 0.8× 682 0.6× 271 0.7× 75 2.8k
Shuichi Miyawaki Japan 26 641 0.3× 2.0k 0.9× 864 0.6× 239 0.2× 597 1.6× 121 2.8k
Rajko Kušec Croatia 24 887 0.4× 1.0k 0.4× 979 0.7× 225 0.2× 280 0.7× 104 2.0k
Vibe Skov Denmark 24 955 0.4× 754 0.3× 725 0.5× 452 0.4× 152 0.4× 107 1.8k
Çiğdem Altay Türkiye 27 1.2k 0.5× 1.1k 0.5× 734 0.5× 281 0.2× 116 0.3× 118 2.4k
James D. Hoyer United States 29 1.2k 0.5× 1.3k 0.5× 803 0.6× 98 0.1× 471 1.2× 121 2.8k

Countries citing papers authored by Stéphane Giraudier

Since Specialization
Citations

This map shows the geographic impact of Stéphane Giraudier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Giraudier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Giraudier more than expected).

Fields of papers citing papers by Stéphane Giraudier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Giraudier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Giraudier. The network helps show where Stéphane Giraudier may publish in the future.

Co-authorship network of co-authors of Stéphane Giraudier

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Giraudier. A scholar is included among the top collaborators of Stéphane Giraudier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Giraudier. Stéphane Giraudier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ganesan, Saravanan, Evelyne Lauret, Nabih Maslah, et al.. (2024). Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms. Blood Cancer Journal. 14(1). 1–1. 5 indexed citations
2.
Maslah, Nabih, Lina Benajiba, Stéphane Giraudier, Jean‐Jacques Kiladjian, & Bruno Cassinat. (2023). Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape. Leukemia. 37(5). 957–963. 9 indexed citations
3.
Maslah, Nabih, Emmanuelle Verger, Christine Chomienne, et al.. (2021). Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement. British Journal of Haematology. 196(3). 676–680. 7 indexed citations
4.
Zhao, Lin‐Pierre, Nabih Maslah, Emmanuelle Verger, et al.. (2021). Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Blood. 138(21). 2142–2148. 20 indexed citations
5.
Girel, Simon, Vincent Bansaye, Catherine Lacout, et al.. (2021). Multistage hematopoietic stem cell regulation in the mouse: A combined biological and mathematical approach. iScience. 24(12). 103399–103399. 1 indexed citations
6.
Maslah, Nabih, Valérie Edmond, Bruno Cassinat, et al.. (2020). JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML. The Journal of Experimental Medicine. 218(2). 19 indexed citations
7.
Cassinat, Bruno, Barbara Mora, Emmanuelle Verger, et al.. (2020). Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. Blood Advances. 4(15). 3708–3715. 30 indexed citations
8.
Soret, Juliette, Nicolas Gauthier, Emmanuelle Verger, et al.. (2020). SF3B1 mutations in the Driver Clone Increase the Risk of Evolution to Myelofibrosis in Patients with Myeloproliferative Neoplasms (MPN). Blood. 136(Supplement 1). 1–1. 2 indexed citations
9.
10.
Verger, Emmanuelle, Bruno Cassinat, Aurélie Chauveau, et al.. (2015). Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations. Blood. 126(24). 2585–2591. 109 indexed citations
11.
Zysman, M., Philippe Caramelle, Sabine Le Gouvello, et al.. (2015). Lack of Transcription Factor p53 Exacerbates Elastase-Induced Emphysema in Mice. American Journal of Respiratory Cell and Molecular Biology. 54(2). 188–199. 4 indexed citations
12.
Baulny, Hélène Ogier de, Renata Kozyraki, Sandrine Passemard, et al.. (2012). How can cobalamin injections be spaced in long-term therapy for inborn errors of vitamin B12 absorption?. Molecular Genetics and Metabolism. 107(1-2). 66–71. 15 indexed citations
13.
Plo, Isabelle, Mayuka Nakatake, Laurent Malivert, et al.. (2008). JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders. Blood. 112(4). 1402–1412. 133 indexed citations
14.
Kiladjian, Jean‐Jacques, Francisco Cervantes, Frank W.G. Leebeek, et al.. (2008). The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood. 111(10). 4922–4929. 227 indexed citations
15.
Wagner‐Ballon, Orianne, Hédia Chagraoui, Eric Prina, et al.. (2006). Monocyte/Macrophage Dysfunctions Do Not Impair the Promotion of Myelofibrosis by High Levels of Thrombopoietin. The Journal of Immunology. 176(11). 6425–6433. 18 indexed citations
16.
Mannone, Lionel, Claude Gardin, Jérôme Bernard, et al.. (2006). High‐dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study. British Journal of Haematology. 133(5). 513–519. 72 indexed citations
17.
Blanchet, Benoı̂t, Anne Hulin, Bijan Ghaleh, et al.. (2006). Distribution of calcineurin activity in blood cell fractions and impact of tacrolimus inhibition. Fundamental and Clinical Pharmacology. 20(2). 137–144. 15 indexed citations
18.
Gannagé, Monique, Michał Abel, Marion Lambert, et al.. (2005). Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy. The Journal of Immunology. 174(12). 8210–8218. 83 indexed citations
19.
20.
Komura, Emiko, Hédia Chagraoui, Benoı̂t Blanchet, et al.. (2003). Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression. Experimental Hematology. 31(7). 622–630. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan O’Brien Breakdown of academic impact, for papers by Luca Malcovati Breakdown of academic impact, for papers by Chloé James Breakdown of academic impact, for papers by Jaroslav F. Prchal Breakdown of academic impact, for papers by Jan Samuelsson Breakdown of academic impact, for papers by Shuichi Miyawaki Breakdown of academic impact, for papers by Rajko Kušec Breakdown of academic impact, for papers by Vibe Skov Breakdown of academic impact, for papers by Çiğdem Altay Breakdown of academic impact, for papers by James D. Hoyer
Rankless by CCL
2026